Abstract
Prototheca sp. can assume high economic significance in the dairy industry and pose a potential risk for the public health. We investigated the in vitro susceptibility of Prototheca isolates retrieved from mastitic milk (P. zopfii and P. blaschkeae) to different pH buffers and salt concentrations using a microbroth assay adapted from the Clinical Laboratory Standards Institute guidelines. Different pH buffer solutions ranging from pH 1 to pH 12 and different sodium chloride concentrations, 4.5, 9 and 18%, were tested. P. zopfii strains presented an optimal growth between pH 5 and 9, a complete growth inhibition at pH 3, and limited growth at pH 1 and 12, whereas P. blaschkeae strains showed higher susceptibility to all pH values except for pH 3 where it demonstrated a moderate growth when compared to P. zopfii strains. When salinity was incremented, P. blaschkeae was more resistant than P. zopfii, although a reduction in growth for all strains of Prototheca was observed. This study demonstrated differences in the in vitro susceptibilities of P. zopfii and P. blaschkeae to different pH and salt concentrations and intend to be a contribution on the understanding of some of the physiologic features that can be associated with the survival of these microalgae in the environment.
Similar content being viewed by others
References
Marques S, Silva E, Kraft C, Carvalheira J, Videira A, Huss VAR, et al. Bovine mastitis associated with Prototheca blaschkeae. J Clin Microbiol. 2008;46:1941–5.
Roesler U, Moller A, Hensel A, Baumann D, Truyen U. Diversity within the current algal species Prototheca zopfii: a proposal for two Prototheca zopfii genotypes and description of a novel species, Prototheca blaschkeae sp.nov. Int J Syst Evol Microbiol. 2006;56:1419–25.
DiPersio JR. Prototheca and protothecosis. Clin Microbiol Newsl. 2001;23:115–20.
Anderson KL, Walker RL. Sources of Prototheca spp. in a dairy herd environment. J Am Vet Med Assoc. 1988;193:553–6.
Lass-Florl C, Mayr A. Human protothecosis. Clin Microbiol Rev. 2007;20:230–42.
Pore RS, Barnett EA, Barnes WC Jr, Walker JD. Prototheca ecology. Mycopathologia. 1983;81:49–62.
Pore RS. Prototheca and chlorella. In: Ajello L, Hay RJ, editors. Topley & Wilson’s microbiology and microbial infections, vol. 4. London: Arnold Publication; 1998. p. 631–43.
Thompson G, Silva E, Marques S, Muller A, Carvalheira J. Algaemia in a dairy cow by Prototheca blaschkeae. Med Mycol. 2009;47:1–5.
Melville PA, Watanabe ET, Benites NR, Ribeiro AR, Silva JA, Garino Junior F, et al. Evaluation of the susceptibility of Prototheca zopfii to milk pasteurization. Mycopathologia. 1999;146:79–82.
Malinowski E, Lassa H, Klossowska A. Isolation of Prototheca zopfii from inflamed secretion of udders. Bull Vet Inst Pulawy. 2002;46:295–9.
Roesler U, Hensel A. Longitudinal analysis of Prototheca zopfii-specific immune responses: correlation with disease progression and carriage in dairy cows. J Clin Microbiol. 2003;41:1181–6.
Hightower KD, Messina JL. Cutaneous protothecosis: a case report and review of the literature. Cutis. 2007;80:129–31.
Hollingsworth SR. Canine protothecosis. Vet Clin North Am Small Anim Pract. 2000;30:1091–101.
Corbellini LG, Driemeier D, Cruz C, Dias MM, Ferreiro L. Bovine mastitis due to Prototheca zopfii: clinical, epidemiological and pathological aspects in a Brazilian dairy herd. Trop Anim Health Prod. 2001;33:463–70.
Rodriguez E. Prototheca infections. In: Harvard Wide Conference. 2003. http://www.mgh.harvard.edu/id/hms/handouts2002/prototheca.pdf. Accessed 10 Oct 2004.
Janosi S, Ratz F, Szigeti G, Kulcsar M, Kerenyi J, Lauko T, et al. Review of the microbiological, pathological, and clinical aspects of bovine mastitis caused by the alga Prototheca zopfii. Vet Q. 2001;23:58–61.
Piyophirapong S, Linpiyawan R, Mahaisavariya P, Muanprasat C, Chaiprasert A, Suthipinittharm P. Cutaneous protothecosis in an AIDS patient. Br J Dermatol. 2002;146:713–5.
CLSI. NCCLS document M27-A2. In: National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. National Committee for Clinical Laboratory Standards. 2002;22.
European C. European Pharmacopeia. 6th ed. Strasbourg; 2007. p. 508–14.
USP C. The United States Pharmacopeia. Rockville; 2008. p. 813–4.
Zaitz C, Godoy AM, Colucci FM, de Sousa VM, Ruiz LR, Masada AS, et al. Cutaneous protothecosis: report of a third Brazilian case. Int J Dermatol. 2006;45:124–6.
Tsuji H, Kano R, Hirai A, Murakami M, Yanai T, Namihira Y, et al. An isolate of Prototheca wickerhamii from systemic canine protothecosis. Vet Microbiol. 2006;118:305–11.
Costa EO, Melville PA, Ribeiro AR, Watanabe ET, Parolari MC. Epidemiologic study of environmental sources in a Prototheca zopfii outbreak of bovine mastitis. Mycopathologia. 1997;137:33–6.
Acknowledgments
This work was supported by Fundação para a Ciência e Tecnologia, Portugal, grant SFRH/BD/28892/2006.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marques, S., Silva, E., Carvalheira, J. et al. In Vitro Susceptibility of Prototheca to pH and Salt Concentration. Mycopathologia 169, 297–302 (2010). https://doi.org/10.1007/s11046-009-9254-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-009-9254-0